Inter-cellular signal transduction by alveolar macrophages in acute lung injury
急性肺损伤中肺泡巨噬细胞的细胞间信号转导
基本信息
- 批准号:07407045
- 负责人:
- 金额:$ 8.51万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To examine the role of alveolar macrophages (AMs) in initial PMN recruitment after Gram-negative bacterial infection, we depleted AMs in rodent by aerosol inhalation of negatively charged large oligolamellar liposomes encapsulating clodronate disodium (Cl2MDP-liposomes). This method cleared over 95% of AMs from the lungs without causing lung damage or airspace neutrophilia. Depletion of AMS attenuated initial PMN recruitment and chemokine production in Pseudomonas aeruginosa pneumonia in rats. To further evaluate the role of AMs in acute and subacute Pseudomonas aeruginosa pneumonia in mice, AM-depleted mice and control mice were compared after intratracheally infected by P. aeruginosa. In addition to monitoring neutrophils recrutiment and chemokine releases, lung injury was evaluated soon after infection (8 h) and a later time (48 h). At 8 h, depletion of AMs reduced neutrophils recrutiment, chemokine release and lung injury. At 48 h, however, depletion of AMs decreased bacterial clearance and resulted in delayed movement of neutrophils from the site of inflammation with aggravated lung injury. In the setting of 50% lethal amount of bacteria instillation in control mice, the survival rate of AM-depleted mice showed low mortality within 24 h of infecton, but high mortality. at later time in contrast to non-AM-depleted mice. These results demonstrate that depletion of AMs has beneficial early effects but deleterious late effects on lung injury and survival in P. aeruginosa pneumonia.
为了研究肺泡巨噬细胞(AM)在革兰氏阴性细菌感染后初始PMN募集中的作用,我们通过雾化吸入包封氯膦酸二钠的带负电荷的大寡层脂质体(Cl 2 MDP-脂质体)来消耗啮齿动物中的AM。这种方法从肺部清除了超过95%的AM,而不会造成肺损伤或空气嗜酸性粒细胞。AMS消耗减弱了大鼠铜绿假单胞菌肺炎中初始PMN募集和趋化因子的产生。为了进一步评价AM在小鼠急性和亚急性铜绿假单胞菌肺炎中的作用,在铜绿假单胞菌肠道感染后比较AM去除的小鼠和对照小鼠。除了监测中性粒细胞的募集和趋化因子的释放,肺损伤后不久(8小时)和稍后的时间(48小时)进行了评价。在8小时,耗尽AM减少中性粒细胞的募集,趋化因子释放和肺损伤。然而,在48小时时,AM的消耗减少了细菌清除,并导致中性粒细胞从炎症部位的移动延迟,从而加剧了肺损伤。在对照组小鼠50%致死量细菌滴注的情况下,AM耗竭小鼠在感染后24 h内的存活率较低,但死亡率较高。与非AM耗尽的小鼠相比,在较晚的时间。这些结果表明,在铜绿假单胞菌肺炎中,AM的消耗对肺损伤和存活具有有益的早期效应,但具有有害的晚期效应。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hashimoto S: "Depletion of Alveolar Macrophages decreased neu trophil chemotatis to pseudomonas arrspace infection" Americau J Physiology. 269(発表予定). (1996)
Hashimoto S:“肺泡巨噬细胞的消耗减少了中性粒细胞对假单胞菌感染的趋化”,Americau J Physiology 269(待出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kooguchi K, Hashimoto S, et al.: "Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia"Infection and Immunity. 66. 3164-3169 (1998)
Kooguchi K、Hashimoto S 等人:“肺泡巨噬细胞在铜绿假单胞菌肺炎炎症的引发和调节中的作用”感染和免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kooguchi K, Hashimoto S: "Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia"Infection and Immunity. 66. 3164-3168 (1998)
Kooguchi K、Hashimoto S:“肺泡巨噬细胞在铜绿假单胞菌肺炎炎症的引发和调节中的作用”感染和免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hashimoto S: "Expression of iNOS and inflammatory cytoklnesin alueolar macrophages in ARDS" Am J Resp Crit Care Med. 153. (1996)A588:
Hashimoto S:“ARDS 中 iNOS 和炎性细胞因子肺泡巨噬细胞的表达”Am J Resp Crit Care Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hashimoto S: "Aerosolization of imipenem/cilastatin prevents Psedomonas-induced long injury" J Antimicnb Chemother. 38(5). 809-818 (1996)
Hashimoto S:“亚胺培南/西司他丁的雾化可预防假单胞菌引起的长期损伤”J Antimicnb Chemother。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HASHIMOTO Satoru其他文献
HASHIMOTO Satoru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HASHIMOTO Satoru', 18)}}的其他基金
Abnormal transcriptional regulation in Cockayne syndrome and its effect on neuronal differentiation
Cockayne 综合征转录调控异常及其对神经元分化的影响
- 批准号:
15K06758 - 财政年份:2015
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The analyses of price differential in Japanese natural gas industry
日本天然气行业价格差异分析
- 批准号:
24830032 - 财政年份:2012
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Biomakers associated with ventilator associated lung injury
与呼吸机相关肺损伤相关的生物制造商
- 批准号:
20390460 - 财政年份:2008
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mechanism of cell damage and repair in acute lung injury
急性肺损伤的细胞损伤与修复机制
- 批准号:
16390457 - 财政年份:2004
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Apoptosis and inflammatory cell in the pathogenesis of acute lung injury
急性肺损伤发病机制中的凋亡和炎症细胞
- 批准号:
13470326 - 财政年份:2001
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
APOPTOSIS IN ACUTE LUNG INJURY
急性肺损伤中的细胞凋亡
- 批准号:
10470322 - 财政年份:1998
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 8.51万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:














{{item.name}}会员




